Liste des médicaments et vaccins
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| NEOTONE RADIANCE SPF 50+ Crème Fl/30mL | AQUA (42,98%) + HOMOSALATE (7%) + DICAPRYLYL CARBONATE (5,87%) + BUTYLOCTYL SALICYLATE (5%) + METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL (4%) + CAPRYLIC/CAPRIC TRIGLYCERIDE (3,99%) + BUTYL METHOXYDIBENZOYLMETHANE (3%) + DIISOPROPYL ADIPATE (3%) + ETHYLHEXYL METHOXYCRYLENE (35%) + NIACINAMIDE (3%) + STEARETH-21 (2,5%) + BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE (2%) + STYRENE/ACRYLATES COPOLYMER (1,76%) + GLYCERYL STEARATE (1,75%)+ PEG-100 STEARATE (1.75%) +1,2-HEXANEDIOL (1,7%) + SILICA (1,5%) + GLYCERIN (1,45%) | ISISPHARMA DERMATOLOGIE | France | 5575.63 | AC_2020_8011 | 2025-10-15 |
| NEOTONE SERUM Fl/25mL | WATER (AQUA) (61,43%) + DIMETHICONE (6,52%) + GLYCOLIC ACID (5,99%) + CAPRYLIC/CAPRIC TRIGLYCERIDE (3,99%) + ALCOHOL DENAT (3,84 %) + GLYCERIN (3,21%) ISOPENTYLDIOL (3%) + NIACINAMIDE (3%) + SODIUM HYDROXIDE (1,87%) + POLYACRYLATE CROSSPOLYMER-6 (1,152%) + HYDROXYETHYLCELLULOSE (1,08%) + 1,2-HEXANEDIOL (1%) | ISISPHARMA DERMATOLOGIE | France | 5247.66 | AC_2020_8004 | 2025-11-16 |
| NEOXICAM 15mg Comprimé B/10 | MELOXICAM | NEOPHARMA | Emirats arabes unis | 1400 | AMM_2018_4035 | 2023-08-28 |
| NEOXICAM 7,5mg Comprimé B/10 | MELOXICAM | NEOPHARMA | Emirats arabes unis | 900 | AMM_2018_4036 | 2023-08-28 |
| NERVIT (10mg+4mg+4mg+40mg+8mcg+6mg)/2mL Solution injectable en ampoule B/10 | THIAMINE + RIBOFLAVINE + PYRIDOXINE + NICOTINAMIDE + CYANOCOBALAMINE + D-PANTHENOL | ZRENIE HEALTHCARE PVT. LTD. | Inde | 1639.89 | AMM_2016_628 | 2029-07-12 |
| NESET 10mg Comprimé B/10 | CETIRIZINE | NABIQASIM INDUSTRIES (PVT) LTD | Pakistan | 787.15 | AMM_2020_9074 | 2026-10-31 |
| NESTEFFER 1000mg Comprimé effervescent B/8 | PARACETAMOL | ACTON PHARMA PVT. LTD | Inde | 623.15 | 9876/14 | 2024-03-31 |
| NESTEFFER 125mg/5mL Suspension buvable Fl/100mL | PARACETAMOL | ACTON PHARMA PVT. LTD | Inde | 655.95 | 10028/14 | 2024-09-30 |